News
A proud moment for Septodont
27 December 2022
Read now
Septodont has announced an agreement to acquire a controlling stake in Inibsa, with Acteon as a non-controlling partner. Inibsa, based near Barcelona, Spain, specializes in dental products. This investment aims to enhance services for dental practitioners and their patients globally. The transaction is expected to be completed by the end of the year, pending regulatory approvals. If you have any questions, you can contact your local representative.
Inibsa has more than 75 years of experience providing products and services to healthcare professionals with an increasing focus on the dental industry. With a presence in more than 60 countries, this represents a unique opportunity for the company to develop its sales in dental products worldwide.
Septodont and Inibsa are focused on the needs of dental professionals and their patients. As two key companies in the dental health industry, they share the ambition to provide high quality products and solutions to customers worldwide. Acteon has developed a strong supply relationship with Inibsa. Acteon’s minority investment in Inibsa aims at developing further the existing partnership between the two companies.
“This acquisition of control of Inibsa will expand Septodont’s development in dental products and help us further strengthen our geographical footprint”, said Olivier Schiller, CEO of Septodont. “This is an important acquisition for us that will provide compelling value creation and accelerated growth opportunities given the complementary nature of our assets and teams”.
“We are thrilled to invest in Inibsa alongside Septodont. It will give Acteon the opportunity to strengthen its manufacturing position in the area of dental pharmaceutical products in Europe and Asia”, added Markus Boehringer, CEO of Acteon. “Our shareholders were very supportive of this acquisition, which is the perfect complement of our current strategy, focusing on effective innovation, enhancing our customer service and strengthening operational capabilities.”
“Today’s announcement marks the start of an exciting new chapter for Inibsa. In Septodont and Acteon, we have strong partners who are committed to strengthening and growing our business”, said Eduard Lopez, General Manager of Inibsa.
The acquisition is subject to customary closing conditions and regulatory approvals. Completion is expected before the end of the year.
Sign up now and get an exclusive access to: